Literature DB >> 19093363

[Effect of GABA-positive drugs on the background and superior sagittalis sinus-electrostimulated activity of neurons in the nucleus trigeminalis caudalis of rats].

A Iu Sokolov, A V Amelin, Iu D Ignatov, S S Panteleev.   

Abstract

There is extensive clinical evidence for the high efficacy of GABA-ergic drugs in prophylactic and abortive treatment of migraine and cluster headache, while the mechanisms of anticephalgic drugs action are not clear, in particular, because of insufficient number of investigations on experimental headache models. In this study, the influence of baclofen (i.v.) in doses 2.5, 5, 10, and 15 mg/kg and valproate (i.v.) in doses 25, 50, 100, and 200 mg/kg on the background activity of the trigeminal nucleus caudalis neurons and that evoked by electrical stimulation of the superior sagittalis sinus was investigated in series of acute experiments on rats. It is established, that baclofen and valproate reduce both the background and evoked activity of trigeminal complex neurons in dose-dependent manner, thus determining the role of GABA-A and GABA-B receptors in realization of this effect. These results provide experimental basis for explanation of the clinical efficacy of the GABA-positive drugs in vascular headaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19093363

Source DB:  PubMed          Journal:  Eksp Klin Farmakol        ISSN: 0869-2092


  2 in total

1.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

2.  Paroxetine engenders analgesic effects through inhibition of p38 phosphorylation in a rat migraine model.

Authors:  Chuanming Wang; Wei Bi; Yanran Liang; Xiuna Jing; Songhua Xiao; Yannan Fang; Qiaoyun Shi; Enxiang Tao
Journal:  Neural Regen Res       Date:  2012-05-05       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.